Scleroderma

1
Scleroderma

• Three major disease subsets Based on extent of
  skin dz
• Diffuse disease - skin abnormalities extending to
  the proximal extremities (AKA - PSS)
• Limited disease AKA "CREST" syndrome
• Calcinosis, Raynauds, Esophageal dysmotility
  Sclerodactyly, Telangiectasias
• Localized Scleroderma
• Morphea manifests as focal patches
• Linear scleroderma band-like (linear) areas of
  thickening. (Coup de Sabre)

2
(No Transcript)
3
Other causes of Tight Skin

• Pseudosclerodactyly
• IDDM, Hypothyroidism
• Drugs Tryptophan, bleomycin, pentazocine, vinyl
  chloride, solvents
• Eosinophilic fasciitis
• Overlap Conditions
• Scleroderma-like conditions
• Eosinophil myalgia syndrome (tryptophan)
• Porphyria cutanea tarda

4
ACR Systemic Sclerosis Preliminary Classification
Criteria

• Major Criterion
• Proximal Scleroderma
• Minor Criteria
• Sclerodactyly
• Digital pitting or scars or loss of finger pad
• Bibasilar pulmonary fibrosis

One major and two minor required for diagnosis
5
Scleroderma Onset

• 80 females
• Age 50 are lt 40 yrs _at_ onset (20-50)
• Incidence 20/million/year
• Raynauds
• Swollen or puffy digits
• Loss of skin folds, no hair growth
• Digital pulp sores/scars
• Arthralgias gtgt Arthritis

6
SclerodermaA disorder of Collagen, Vessels

• Etiology unknown?
• Autoimmune disorder suggested by the presence of
  characteristic autoantibodies such as ANA,
  anti-centromere and anti-SCL-70 antibodies.
• Pathology
• Early dermal changes lymphocytic infiltrates
  primarily of T cells
• Major abnormality is collagen accumulation with
  fibrosis.
• Small to medium-sized blood vessels, which show
  bland fibrotic change.
• Small thrombi may form on the altered intimal
  surfaces.
• Microvascular disease

Cold
Normal
Cold
PSS
7
PSS - Clinical

• Skin
• Skin thickening is most noticeable in the hands,
  looking swollen, puffy, waxy.
• Thickening extends to proximal extremity, truncal
  and facial skin thickening is seen.
• Raynaud's phenomenon is present.
• Digital pits or scarring of the distal digital
  pulp
• Musculoskeletal Arthralgias and joint stiffness
  are common.
• Palpable tendon friction rubs associated with an
  increased incidence of organ involvement.
• Muscle weakness or frank myositis can be seen.

8
(No Transcript)
9
(No Transcript)
10
(No Transcript)
11
(No Transcript)
12
(No Transcript)
13
(No Transcript)
14
(No Transcript)
15
(No Transcript)
16
PSS - Clinical

• Gastrointestinal Esophageal dysmotility,
  dysphagia, malabsorptive or blind loop syndrome,
  constipation.
• Renal Kidney involvement is an ominous finding
  and important cause of death in diffuse
  scleroderma. A hypertensive crisis (AKA renal
  crisis) may herald the onset of rapidly
  progressive renal failure.

17
(No Transcript)
18
(No Transcript)
19
(No Transcript)
20
Pulmonary Manifestations of PSS

• Dyspnea
• Pulmonary HTN only in CREST
• Interstitial fibrosis (fibrosing alveolitis)
• High resolution CT vs Galium Scan
• Major cause of death
• RARE
• Pulmonary embolism
• Pulmonary vasculitis

21
Cardiac Findings in PSS

• Myocardial fibrosis
• Dilated cardiomyopathy
• Cor pulmonale
• Arrhythmias
• Pericarditis
• Myocarditis
• Congestive heart failure

22
(No Transcript)
23
Comparison CREST v. PSS
Ab antibody Relative percentages
81-100 61-80 41-60 21-40
1-20
24
Treatment of Scleroderma

• Localized none
• Raynauds warmth, skin protection, vasodilator
  therapy
• CREST none
• PSS none proven
• Penicillamine controversy
• Cytoxan for lung disease?
• Steroids have no value

25
PolymyositisDermatomyositis

• FM 21
• Acute onset
• Weakness ( myalgia) Proximal gt Distal
• Skeletal muscle dysphagia, dysphonia
• Sx Rash, Raynauds, dyspnea
• 65 elevated CPK, aldolase
• 50 ANA ()
• 90 EMG 85 muscle biopsy

26
Proposed Criteria for Myositis

• Symmetric proximal muscle weakness
• Elevated Muscle Enzymes (CPK, aldolase, AST, ALT,
  LDH)
• Myopathic EMG abnormalities
• Typical changes on muscle biopsy
• Typical rash of dermatomyositis
• PM Dx is Definite w/ 4/5 criteria and Probable
  w/3/5 criteria
• DM Dx Definite w/ rash and 3/4 criteria and
  Probable w/ rash and 2/4 criteria

27
Polymyositis ClassificationBohan Peter

• Primary idiopathic dermatomyositis
• Primary idiopathic polymyositis
• Adult PM/DM associated with neoplasia
• Childhood Dermatomyositis (or PM)
• often associated with vasculitis
• Myositis associated with collagen vascular disease

28
(No Transcript)
29
MYOPATHY HISTORICAL CONSIDERATIONS

• Age/Sex/Race
• Acute vs. Insidious Onset
• Distribution Proximal vs. Distal
• Pain?
• Drugs/Pre-existing Conditions
• Neuropathy
• Systemic Features

30
(No Transcript)
31
MYOPATHIIES

• Toxic/Drugs
• Etoh, Cocaine, Steroids, Plaquenil,
  Penicilamine, Colchicine, AZT, Lovastatin,
  Clofibrate, Tryptophan, Taxol, Emetine
• Infectious
• Coxackie A9, HBV, HIV, Stept., Staph,
  Clostridial, Toxoplasma, Trichinella
• Inflammatory Myopathies
• Congenital
• Neuropathic/Motor Neuron Disorders
• Endocrine/Metabolic

32
NONMYOPATHIC CONSIDERATIONS

• Fibromyalgia/Fibrositis/Myofascial Pain Disorder
• Polymyalgia Rheumatica
• Caucasians, gt 55 yrs, MF
• ESR gt 100, normal strength, no synovitis
• RA
• SLE
• Adult Still's Disease

33
INFLAMMATORY MYOSITISImmunopathogenesis

• Infiltrates - T cells (HLA-DR) monocytes
• Muscle fibers express class I II MHC Ags
• T cells are cytotoxic to muscle fibers
• t-RNA antibodies role? FOUND IN lt50 OF PTS
• Infectious etiology? Viral implicated
• HLA-B8/DR3 in childhood DM
• DR3 and DRW52 with t-RNA synthetase Ab

34
DERMATOMYOSITIS5 Skin Features

• Heliotrope Rash over eyelids
• Seldom seen in adults
• Gottrons Papules MCPs, PIPs, MTPs, knees, elbows
• V-Neck Rash violaceous/erythema anterior chest
  w/ telangiectasias
• Periungual erythema, digital ulcerations
• Calcinosis

35
(No Transcript)
36
(No Transcript)
37
(No Transcript)
38
(No Transcript)
39
(No Transcript)
40
(No Transcript)
41
Calcinosis
42
(No Transcript)
43
DIAGNOSTIC TESTING

• Physical Examiniation Motor Strength (Gowers
  sign), Neurologic Exam
• Acute phase reactants unreliable
• Muscle Enzymes
• CPK elevated gt65 gt10 MB fraction is possible
• Muscle specific- Aldolase, Troponin, Carb.
  anhydraseIII
• AST gt LDH gt ALT
• Beware of incr. creatinine (ATN) and
  myoglobinuria
• Electromyogram increased insertional activity,
  amplitude, polyphasics, associated neuropathic
  changes, incremental/decremental MU changes

44
DIAGNOSTIC TESTING

• Muscle Biopsy (an URGENT not elective procedure)
• Call the neuropathologist! 85 Sensitive.
• Biopsy involved muscle (MRI guided)
• Avoid EMG/injection sites or sites of trauma
• Magnetic Resonance Imaging - detects incr. water
  signal, fibrous tissue, infiltration,
  calcification
• Investigational Tc-99m Scans, PET Scans
• Serologic Tests ANA () 60, Abs against
  t-RNA synthetases

45
INFLAMMATORY MYOSITISBiopsy Findings

• Inflammatory cells
• Edema and/or fibrosis
• Atrophy/ necrosis/ degeneration
• Centralization of nuclei
• Variation in muscle fiber size
• Rarely, calcification

46
(No Transcript)
47
(No Transcript)
48
Anti-synthetase syndrome ILD, fever, arthritis,
Raynauds, Mechanics hands
49
Autoantibodies in PM/DM
Ab Freq () Clinical Syndrome
ANA 50 Myositis
U1-RNP 15 SLE myositis
Ku lt5 PSS myositis
Mi2 30 Dermatomyositis
PM1 15 PSS PM overlap
Jo-1 25 Arthritis ILD arthritis
SS-B (La) lt5 SLE,Sjogrens, ILD, PM
PL-12,7 lt5 ILD PM
50
(No Transcript)
51
(No Transcript)
52
INFLAMMATORY MYOSITIS

• NORMAL/NOT INVOLVED
• Face Uncommon
• Renal
• RES LN, spleen, liver (enzymes from muscle)
• NOT UNCOMMON
• RA-like arthritis
• Fever/chills/night sweats
• Myalgias

53
MALIGNANCY MYOSITIS

• Controversial
• Reports range from 10-25
• If real, men over age 50 yrs at greatest risk
• Common tumors Breast, lung, ovary, stomach,
  uterus, colon
• 60 the myositis appears 1st, 30 neoplasm 1st,
  and 10 contemporaneously
• Avoid invasive, expensive searches for occult
  neoplasia

54
PM/DM Complications

• PULMONARY
• Aspiration pneumonitis
• Infectious pneumonitis
• Drug induced pneumonitis
• Intercostal, diagphragm involvement
• Fibrosing alveolitis
• RARE
• Pulmonary vasculitis
• Pulmonary neoplasia

• CARDIAC
• Elev. CPK-MB
• Mitral Valve prolapse
• AV conduction disturbances
• Cardiomyopathy
• Myocarditis

55
PM/DM Diagnosis

• Symmetric progressive proximal weakness
• Elevated muscle enzymes (CPK, LFTs)
• Muscle biopsy evidence of myositis
• EMG inflammatory myositis
• Characteristic dermatologic findings

56
INFLAMMATORY MYOSITISTreatment

• Early Dx, physical therapy, respiratory Rx
• Corticosteroids 60-80 mg/day
• 80 respond within 12 weeks
• Steroid resistant
• Methotrexate
• Azathioprine
• IVIG, Cyclosporin, Chlorambucil unproven
• No response to apheresis

57
PROGNOSIS

• Poor in pts. with delayed Dx, low CPK, early
  lung or cardiac findings, malignancy
• Neoplasia in 10 of adults
• PT for muscle atrophy, contractures, disability
• Kids50 remission, 35 chr active disease
• Adult lt 20 yrs. do better than gt55 yrs.
• Adults Mortality rates betw. 28-47 _at_ 7 yrs.
• Relapses functional disability are common
• Death due to malignancy, sepsis, pulm. or
  cardiac failure, and complications of therapy

58
RHABDOMYOLYSIS

• Injury to the sarcolemma of skeletal muscle with
  systemic release of muscle macromolecules such as
  CPK, aldolase, actin, myoglobin, etc
• Maybe LIFE-THREATENING from hyperkalemia, met.
  acidosis, ATN from myoglobinuria
• Common causes EtOH, Cocaine, K deficiency,
  infection, PM/DM, infection (clostridial, staph,
  strept), exertion/exercise, cytokines

59
INCLUSION BODY MYOSITIS

• Bimodal age distribution, maybe hereditary
• Slow onset, progressive weakness
• Painless, distal and proximal weakness
• Normal or mildly elevated CPK
• Poor response to corticosteroids
• Dx light microscopy may be normal or show CD8
  lymphs. Tubulofilamentous inclusion bodies on
  electron microscopy
• Role for amyloid?

60
Inflammatory Myositis

• Polymyositis (PM) and dermatomyositis (DM) are
  types of idiopathic inflammatory myopathy (IIM).
  IIM are characterized clinically by proximal
  muscle weakness
• Etiology There is now known etiology.
• Demographics PM is more common than DM in
  adults. Peak incidence occurs between 40 and 60
  yrs. FM 21
• Muscles Proximal muscle weakness, dysphagia,
  aspiration. respiratory failure or death.
• Skin Gottron's papules, heliotrope rash, "V"
  neck rash, periungual erythema, "Mechanic's
  hands", calcinosis
• Dx Muscle enzymes (CPK, aldolase), EMG, Biopsy
• Rx Steroids, MTX, Azathioprine, IVIG